Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic cancer; status complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Myeloproliferative Diseases
• Myelodysplastic Syndromes
• Myelofibrosis

Drugs mentioned

• busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant

Snippet

Sponsor: University of Nebraska | Conditions: Graft Versus Host Disease, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-04-03